FACS PURIFICATION OF BLAST CELLS IN MDS IMPROVES THE FISH DETECTION RATE FOR DEL(5Q) AND DEL(20Q), BUT NOT FOR DEL(7Q) OR T8

被引：0
|
作者：
Pereira, M. [1 ,2 ]
Marques, G. [3 ]
Lima, J. [3 ]
Reis, R. [3 ]
Coelho, A. [3 ]
Jorge, L. [3 ]
Pedreiro, S. [4 ]
Ribeiro, L. [1 ]
Paiva, A. [4 ]
Rodrigues, F. [3 ]
机构：
[1] Coimbra Univ Hosp Ctr, Clin Hematol Dept, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Coimbra, Portugal
[3] Coimbra Univ Hosp Ctr, Clin Pathol Dept, Coimbra, Portugal
[4] Coimbra Univ Hosp Ctr, Flow Cytometry Unit, Coimbra, Portugal
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1188
引用
收藏
页码：488 / 488
页数：1
相关论文
共 50 条
  • [21] Acute basophilic leukaemia secondary to MDS with isolated del(5q)
    Loyola, Ines
    Fernandez, Raquel
    Trastoy, Ariana
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 817 - 817
  • [22] Loss of CTNNA1 in MDS and/or AML with del(5q).
    Liu, TGX
    Becker, MW
    Hsu, K
    Deng, M
    Clarke, MF
    Look, AT
    BLOOD, 2003, 102 (11) : 914A - 914A
  • [23] Lenalidomide in del 5q MDS: Responses and side effects revisited
    Tiu, Ramon V.
    Sekeres, Mikkael A.
    LEUKEMIA RESEARCH, 2011, 35 (11) : 1440 - 1441
  • [24] PROGNOSTIC IMPACT OF DER(1;7) IN MDS IS DIFFERENT FROM DEL(7Q)
    Ganster, C.
    Haferlach, C.
    Vandenberghe, P.
    Raynaud, S.
    Sole, F.
    Kroeger, N.
    Platzbecker, U.
    Haase, D.
    Schanz, J.
    HAEMATOLOGICA, 2013, 98 : 80 - 80
  • [25] Genetics of Monosomy 7 and Del(7q) in MDS Informs Potential Therapeutic Targets
    Kerr, Cassandra M.
    Adema, Vera
    Walter, Wencke
    Hutter, Stephan
    Snider, Christina A.
    Nagata, Yasunobu
    Meggendorfer, Manja
    Haferlach, Claudia
    Visconte, Valeria
    Sekeres, Mikkael A.
    Laframboise, Thomas
    Haferlach, Torsten
    Maciejewski, Jaroslaw P.
    BLOOD, 2019, 134
  • [26] Isolated del 20q defines a subgroup of MDS patients with lower blast counts and more frequent thrombocytopenia
    Braun, T.
    de Botton, S.
    Guenda, K.
    Leroux, G.
    Taksin, A.
    Park, S.
    Beyne-Rauzy, O.
    Chevret, S.
    Lazareth, A.
    Terre, C.
    Eclache, V.
    Fenaux, P.
    Ades, L.
    LEUKEMIA RESEARCH, 2009, 33 : S77 - S77
  • [27] ISOLATED DEL 20Q DEFINES A SUBGROUP OF MDS PATIENTS WITH LOWER BLAST COUNTS AND MORE FREQUENT THROMBOCYTOPENIA
    Braun, T.
    De Botton, S.
    Guenda, K.
    Leroux, G.
    Taksin, A. L.
    Park, S.
    Beyne-Rauzy, O.
    Chevret, S.
    Fontenay, M.
    Cassinat, B.
    Lazareth, A.
    Terre, C.
    Vey, N.
    Guerci, A.
    Dreyfus, E.
    Bordessoule, D.
    Stamatoullas, A.
    Castaigne, S.
    Eclache, V.
    Fenaux, P.
    Ades, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 106 - 106
  • [28] Where Does Lenalidomide Fit in Non-del(5q) MDS?
    Aristoteles Giagounidis
    Current Hematologic Malignancy Reports, 2015, 10 : 303 - 308
  • [29] Influence of WHO categories and gender on the prognosis of MDS del(5q) patients
    Lauseker, M.
    Kuendgen, A.
    Giagounidis, A.
    Aul, C.
    Haas, R.
    Schlenk, R.
    Haase, D.
    Platzbecker, U.
    Hasford, J.
    Germing, U.
    LEUKEMIA RESEARCH, 2013, 37 : S68 - S68
  • [30] Where Does Lenalidomide Fit in Non-del(5q) MDS?
    Giagounidis, Aristoteles
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2015, 10 (03) : 303 - 308
12345